Hepatitis B virus X protein induces TNF-α expression via down-regulation of selenoprotein P in human hepatoma cell line, HepG2

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1638, Issue 3, 2003, Pages 249-256

  Yi, Young Su ^a   Park, Sung Gyoo ^a   Byeon, Sung Moo ^a   Kwon, Young Guen ^b   Jung, Guhung ^a  

^a Seoul National University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Antisense; HBx; HepG2; Lipid peroxidation; SeP; TNF

Indexed keywords

FERRIC CHLORIDE; MESSENGER RNA; PROTEIN X; SELENOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; HEPATITIS B VIRUS X PROTEIN; PROTEIN; SELENOPROTEIN P; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL CULTURE; CELL LYSATE; CELL STRAIN HEPG2; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; UPREGULATION; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; OXIDATIVE STRESS;

HEPATITIS B VIRUS;

CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; HUMANS; LIPID PEROXIDATION; LIVER NEOPLASMS; OXIDATIVE STRESS; PROTEINS; SELENOPROTEIN P; SELENOPROTEINS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0142107344     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(03)00090-5     Document Type: Article

References (25)

1. Beasley R.P., Hwang L.Y., Lin C.C., Chien C.S. Hepatocellular carcinoma and hepatitis B virus A prospective study of 22 707 men in Taiwan. Lancet. 21:1981;1129-1133.
2. Andrisani O.M., Barnabas S. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis. Int. J. Oncol. 15:1999;373-379.
3. Koike K., Moriya K., Yotsuyanagi H., Iino S., Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J. Clin. Invest. 94:1994;44-49.
4. Wang X.W., Gibson M.K., Vermeulen W., Yeh H., Forrester K., Sturzbecher H.W., Hoeijmakers J.H., Harris C.C. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55:1995;6012-6016.
5. Galle P.R., Hagelstein J., Kommerell B., Volkmann M., Schranz P., Zentgraf H. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology. 106:1994;664-673.
6. Waris G., Huh K.W., Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol. Cell. Biol. 21:2001;7721-7730.
7. Terradillos O., Pollicino T., Lecoeur H., Tripodi M., Gougeon M.L., Tiollais P., Buendia M.A. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene. 17:1998;2115-2123.
8. Moschos M.P. Selenoprotein P. Cell. Mol. Life Sci. 57:2000;1836-1845.
9. Mostert V. Selenoprotein P: properties, functions, and regulation. Arch. Biochem. Biophys. 376:2000;433-438.
10. Hill K.E., Chittum H.S., Lyons P.R., Boeglin M.E., Burk R.F. Effect of selenium on selenoprotein P expression in cultured liver cells. Biochim. Biophys. Acta. 1313:1996;29-34.
11. Mostert V., Dreher I., Kohrle J., Abel J. Transforming growth factor-beta1 inhibits expression of selenoprotein P in cultured human liver cells. FEBS Lett. 460:1999;23-26.
12. Mostert V. Selenoprotein P: properties, functions, and regulation. Arch. Biochem. Biophys. 376:2000;433-438.
13. Burk R.F., Early D.S., Hill K.E., Palmer I.S., Boeglin M.E. Plasma selenium in patients with cirrhosis. Hepatology. 27:1998;794-798.
14. Burk R.F., Hill K.E., Awad J.A., Morrow J.D., Kato T., Cockell K.A., Lyons P.R. Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: assessment of the roles of lipid peroxidation and selenoprotein P. Hepatology. 21:1995;561-569.
15. Gutierrez-Ruiz M.C., Gomez Quiroz L.E., Hernandez E., Bucio L., Souza V., Llorente L., Kershenobich D. Cytokine response and oxidative stress produced by ethanol, acetaldehyde and endotoxin treatment in HepG2 cells. Isr. Med. Assoc. J. 3:2001;131-136.
16. Ramadori G., Armbrust T. Cytokines in the liver. Eur. J. Gastroenterol. Hepatol. 13:2001;777-784.
17. Bradham C.A., Plumpe J., Manns M.P., Brenner D.A., Trautwein C. Mechanisms of hepatic toxicity: I. TNF-induced liver injury. Am. J. Physiol. 275:1998;G387-G392.
18. Iimuro Y., Gallucci R.M., Luster M.I., Kono H., Thurman R.G. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology. 26:1997;1530-1537.
19. Su F., Schneider R.J. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. U. S. A. 94:1997;8744-8749.
20. Lara-Pezzi E., Majano P.L., Gomez-Gonzalo M., Garcia-Monzon C., Moreno-Otero R., Levrero M., Lopez-Cabrera M. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology. 28:1998;1013-1021.
21. Lara-Pezzi E., Armesilla A.L., Majano P.L., Redondo J.M., Lopez-Cabrera M. The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway. EMBO J. 17:1998;7066-7077.
22. Osawa Y., Nagaki M., Banno Y., Yamada Y., Imose M., Nozawa Y., Moriwaki H., Nakashima S. Possible involvement of reactive oxygen species in D-galactosamine-induced sensitization against tumor necrosis factor-alpha-induced hepatocyte apoptosis. J. Cell. Physiol. 187:2001;374-385.
23. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
24. Ohyashiki T., Kadoya A., Kushida K. The role of Fe3+ on Fe2+-dependent lipid peroxidation in phospholipid liposomes. Chem. Pharm. Bull. (Tokyo). 50:2002;203-207.
25. Soejima A., Kaneda F., Manno S., Matsuzawa N., Kouji H., Nagasawa T., Era S., Takakuwa Y. Useful markers for detecting decreased serum antioxidant activity in hemodialysis patients. Am. J. Kidney Dis. 39:2002;1040-1046.